Could an old drug tame COVID-19 immune chaos?
NCT ID NCT04590222
First seen Apr 25, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This study looked at how phenelzine, a drug used for depression, affects immune cells in people with COVID-19. Researchers measured changes in T cells and monocytes from blood samples of 51 patients. The goal was to understand if phenelzine could reduce harmful immune activation, but the study was small and focused on lab results, not patient recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV2 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Bicêtre
Le Kremlin-Bicêtre, 94270, France
Conditions
Explore the condition pages connected to this study.